Combining anxiolytic activity of thymol and trans-ferulic acid: a potential GABAergic intervention
- PMID: 41359056
- DOI: 10.1007/s00210-025-04858-6
Combining anxiolytic activity of thymol and trans-ferulic acid: a potential GABAergic intervention
Abstract
Trans-ferulic acid (TFA), a phenolic acid abundant in fruits and cereals, and thymol (THY), a monoterpenoid phenol from thyme oils, are bioactive natural compounds with notable neuropharmacological potential. This study evaluated the combined anxiolytic effects of THY and TFA in Swiss albino mice, focusing on GABAergic mechanisms and pharmacokinetic profiles through in vivo and in silico methods. Mice received vehicle, diazepam (DZP, 2 mg/kg), TFA (50 mg/kg), THY (50 mg/kg), or their combination (THY + TFA; 50 + 50 mg/kg, p.o.). Behavioral assessments in open-field, swing, hole-cross, and light-dark tests indicated that the combined treatment produced more pronounced effects, markedly reducing locomotor and exploratory activity (e.g., square crosses: 25.8 ± 3.7 vs. 94.6 ± 6.2 in control; hole crosses: 3.4 ± 1.8 vs. 15.6 ± 1.9) and increasing time in the light chamber, consistent with anxiolytic-like activity comparable to DZP. Molecular docking targeted gamma-aminobutyric acid A (GABAA) receptor subunits (α2, α3), and ADME/toxicity profiles were analyzed in silico. Docking analysis revealed moderate binding affinities (BAs) to GABAA receptor subunits AF-P26048-F1 (α2 subunit) (- 5.8 kcal/mol) and 8G4X (α3 subunit) (- 5.3 kcal/mol) for TFA and α2 (- 4.7 kcal/mol) and α3 (- 5.6 kcal/mol) for THY, relative to DZP (- 6.9 kcal/mol). These findings suggest that the THY + TFA combination elicits enhanced GABAergic modulation, offering a potential natural therapeutic strategy for anxiety management with reduced toxicity risk. However, formal interaction analyses (e.g., isobologram or two-way ANOVA) are warranted to confirm the combining effect.
Keywords: Trans-ferulic acid; Anxiolytic; Combining effect; GABAA; In vivo; Thymol.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Competing interests: The authors declare no competing interests.
References
-
- Ahammed S, Chowdhury R, Al Hasan MS, Mia E, Akbor MS, Islam MT, Chowdhury RI, Hossain MS, Ansari IA, Ansari SA, Islam MA, Almarhoon ZM, Sharifi-Rad J, Setzer WN, Islam MT (2025) Anti-arthritic potential of linalool: in vitro, in vivo, and in silico mechanistic insights for safer therapeutic applications. NaunynSchmiedebergs Arch Pharmacol. https://doi.org/10.1007/s00210-025-03984-5 - DOI
-
- Ahmed AH, Alkali YI (2019) In silico pharmacokinetics and molecular docking studies of lead compounds derived from Diospyros mespiliformis. Pharm Tutor 7(3):31–37
-
- Ahmmed MS, Hossan R, Ripu TR, Rahman T, Alshahrani MY, Mia E, Islam MT (2025) Assessment of antiemetic potential of schaftoside through modulation of dopaminergic, serotonergic and muscarinic signaling pathways: in vivo and in silico investigations. Naunyn Schmiedeberg's Arch Pharmacol 1–17. https://doi.org/10.1007/s00210-025-04714-7
-
- Akbor MS, Bappi MH, Prottay AA, Haque MF, Al Hasan MS, Ahammed S, Islam MT (2023) Synergistic hypnotic effects of sesamol and thymol possibly through gabaergic interaction pathway: in vivo and in silico studies. J Biol Regul Homeost Agents, 37(11):6419–6435
-
- Al Hasan MS, Bhuia MS, Chowdhury R, Husain Z, Saifuzzaman M, Mia E, Akbor MS, Yana NT, Islam MA, Ansari SA, Ansari IA, Islam MT (2025) Tangeretin enhances sedative activity of diazepam in Swiss mice through GABAA receptor interaction: in vivo and in silico approaches. Neuroscience 572:1–10. https://doi.org/10.1016/j.neuroscience.2025.03.004 - DOI - PubMed
LinkOut - more resources
Full Text Sources
